SeaStar Medical Holding Corp Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
SeaStar Medical Holding Corp (ICU) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $4.48 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2025-08-13
- SeaStar Medical Holding Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $3.48M, a 28.21% decline year-over-year.
- SeaStar Medical Holding Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $4.84M, a 614.31% increase year-over-year.
- SeaStar Medical Holding Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $678.00K.
- SeaStar Medical Holding Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-03-31 was -$303.00K, a 165.17% decline year-over-year.
- SeaStar Medical Holding Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $1.64M, a 1173.64% increase from fiscal 2023.
- SeaStar Medical Holding Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $129.00K.
- SeaStar Medical Holding Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$463.00K.
- SeaStar Medical Holding Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2021 was -$2.30M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 2 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | $4.48M 10-Q · filed 2025-08-13 | ||||||||
| 2025-03-31 | $3.48M 10-Q · filed 2025-05-14 | ||||||||
| 2024-12-31 | $1.64M 10-K · filed 2025-03-27 | ||||||||
| 2024-09-30 | $1.91M 10-Q · filed 2024-11-13 | ||||||||
| 2024-06-30 | $1.00M 10-Q · filed 2025-08-13 | ||||||||
| 2024-03-31 | $4.84M 10-Q · filed 2025-05-14 | ||||||||
| 2023-12-31 | $129.00K 10-K · filed 2025-03-27 | ||||||||
| 2023-09-30 | $26.00K 10-Q · filed 2024-11-13 | ||||||||
| 2023-06-30 | -$34.00K 10-Q · filed 2024-08-13 | ||||||||
| 2023-03-31 | $678.00K 10-Q · filed 2024-05-14 | ||||||||
| 2022-12-31 | -$463.00K 10-K · filed 2024-04-16 | ||||||||
| 2022-09-30 | -$461.00K 10-Q · filed 2023-11-14 | $65.27K 10-Q · filed 2022-11-14 | |||||||
| 2022-06-30 | $103.00K 10-Q · filed 2023-08-14 | $27.46K 10-Q · filed 2022-08-16 | |||||||
| 2022-03-31 | -$303.00K 10-Q · filed 2023-05-15 | $36.50K 10-Q · filed 2022-05-19 | |||||||
| 2021-12-31 | -$2.30M 10-K · filed 2023-03-30 | $13.18K 10-K · filed 2022-04-06 | |||||||
| 2021-09-30 | $127.45K 10-Q · filed 2022-11-14 | ||||||||
| 2021-06-30 | $301.34K 10-Q · filed 2022-08-16 | ||||||||
| 2021-03-31 | $464.92K 10-Q · filed 2022-05-19 | ||||||||
| 2020-12-31 | $38.39K 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |